Remove Healthcare Remove Medical science Remove Safety Remove Transportation
article thumbnail

Dapagliflozin approved for heart failure across LVEFs

European Pharmaceutical Review

The Medicines and Healthcare products Regulatory Agency ( MHRA ) has granted a licence extension for FORXIGA (dapagliflozin) in Great Britain for symptomatic chronic heart failure (HF) across the full spectrum of left ventricular ejection fraction (LVEF). AstraZeneca’s oral dapagliflozin drug.

article thumbnail

From Europe To The U.S.: A Medtech Executive’s Career Chronicle With Fred Colen

Evolve Your Success

In the end, I decided to become an engineer but from the get-go specialized in medical technology. They allowed me to do some classes in medical science, which was very nice. I got going from the get-go in medical technology. I was inspired by it. Before you continue that, we’ve got to let the audience know what you do.